Pharmacological Activities of Metabolites of a Boronated Dipeptide
Author Information
Author(s): M. C. Miller, III, A. Sood, B. F. Spielvogel, R. P. Shrewsbury, I. H. Hall
Primary Institution: University of North Carolina, Chapel Hill
Hypothesis
The metabolites of N-[(trimethylamineboryl)-carbonyl]-L-phenylalanine methyl ester may be responsible for its pharmacological activity.
Conclusion
Some metabolites showed better cytotoxic activity than the parent compound, while others were less effective in hypolipidemic activity.
Supporting Evidence
- Compounds 2, 3, and 6 showed better cytotoxic activity than the parent compound in certain cancer cell lines.
- Compound 1 was the most effective hypocholesterolemic agent, reducing serum cholesterol levels by 48%.
- Compound 6 provided 100% protection against septic shock in mice.
Takeaway
Scientists tested new compounds made from a drug to see if they worked better against cancer and inflammation. Some worked better than the original drug.
Methodology
The study involved synthesizing metabolites and testing their pharmacological activities in vitro and in vivo using various assays.
Limitations
The study was limited to in vitro and in vivo tests in mice, and the effects in humans are unknown.
Participant Demographics
CF male mice were used for in vivo testing.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website